Medically reviewed by Qin Rao, MD Symptoms of GI bleeding include stomach pain, vomiting blood, or having black, tarry stool.Peptic ulcers are the leading cause of upper GI bleeding, while ...

Among Medicare-certified, single-specialty ASCs, endoscopy is the most common focus, and more than one-third (37%) 1 of certified multi-specialty ASCs have an endoscopy service line. Patient volumes ...

ATLANTA, Georgia — Patients with atrial fibrillation receiving anticoagulant therapy are more likely to experience gastrointestinal (GI) bleeding when treated with rivaroxaban than when treated with ...

LONG BEACH, Calif. -- People with advanced chronic kidney disease (CKD) faced higher rates of potentially fatal gastrointestinal bleeding, a retrospective study found. Those with stage 5 CKD had a 40% ...

PHILADELPHIA — Gastrointestinal (GI) bleeding after percutaneous coronary intervention (PCI) among patients on dual antiplatelet therapy (DAPT) remains risky in terms of morbidity and mortality, but ...

Please provide your email address to receive an email when new articles are posted on . Data suggest that apixaban, a direct oral anticoagulant, may be preferable to other drugs in its category as it ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Some antidepressant medications carry a significant risk of upper-GI hemorrhage. The risk more than triples when the patient also takes certain painkillers. Data from four studies involving 153,000 ...

Dr. Rosario Ligresti explained that while many GISTs are found incidentally, larger tumors may cause anemia, bleeding or swallowing issues. Anemia and gastrointestinal bleeding are among the most ...

Pantoprazole yields lower clinically important upper GI bleeding, with no significant change in mortality vs placebo. HealthDay News — Pantoprazole results in a significantly lower risk for clinically ...

Treatment with thalidomide led to a reduction in bleeding among patients with recurrent bleeding due to small-intestinal angiodysplasia (SIA), a randomized trial showed. In 150 patients, 68.6% of ...